Clinical Trials Browser

NCT02466971 2026-03-18

Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers

Phase 3 Active not recruiting

450 enrolled 11 charts

Gynecologic

Uterine Cervical Neoplasms, Vaginal Neoplasms

NCT05521997 2026-03-13

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

Phase 2 Not yet recruiting

42 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03968406 2026-03-11

Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers

Phase 1 Recruiting

24 enrolled

Gynecologic

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Endometrial Neoplasms

NCT07461142 2026-03-10

RETHEMCOL

Phase NA Not yet recruiting

72 enrolled

Gynecologic

Cervical Cancer by FIGO Stage 2018

NCT04857528 2026-03-04

Detecting HPV DNA in Anal and Cervical Cancers

Recruiting

20 enrolled

GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms

NCT06651697 2026-02-17

BEFORE

Phase 3 Recruiting

300 enrolled

Gynecologic

Pelvic Neoplasms

NCT07340489 2026-01-14

Serplulimab for Locally Advanced Cervical Cancer

Phase 2 Recruiting

216 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06416696 2026-01-02

Toripalimab for High-risk Locally Advanced Cervical Cancer

Phase 2 Active not recruiting

57 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT03614949 2025-12-19

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Phase 2 Active not recruiting

21 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04567771 2025-11-14

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

Phase NA Recruiting

120 enrolled

Gynecologic

Pelvic Inflammatory Disease, Uterine Cervical Neoplasms, Endometriosis, Endometrial Neoplasms

NCT03738228 2025-11-12

Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer

Phase 1 Completed

40 enrolled 17 charts

Gynecologic

Uterine Cervical Neoplasms

NCT04580771 2025-10-10

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

Phase 2 Active not recruiting

22 enrolled

Gynecologic

Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified

NCT07167069 2025-09-11

India HIV-CervCa Project

Active not recruiting

180 enrolled

Gynecologic

Uterine Cervical Neoplasms, HIV Seropositivity

NCT07129525 2025-08-19

HOPE

Not yet recruiting

80 enrolled

GynecologicHead & Neck

Head and Neck Neoplasms, Pelvic Neoplasms, Radiation Injuries

NCT03612791 2025-06-03

ATEZOLACC

Phase 2 Completed

189 enrolled

Gynecologic

Locally Advanced Cervical Cancer

NCT03277482 2025-05-31

Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer

Phase 1 Terminated

16 enrolled

Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT06942416 2025-04-24

Iparomlimab and Tuvonralimab With Chemoradiation for the Treatment of Locally Recurrent and Oligometastatic Cervical Cancer

Phase 2 Recruiting

36 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neoplasm Recurrence, Local, Neoplasms

NCT05857631 2025-04-15

PARCERII

Phase NA Recruiting

90 enrolled

Gynecologic

Uterine Cervical Neoplasms, Endometrial Neoplasms